Over-the-counter Nar­can gets unan­i­mous thumbs-up from FDA ad­vi­sors

Emer­gent BioSo­lu­tions is get­ting clos­er to an ap­proval for over-the-counter Nar­can. On Wednes­day, the FDA’s com­bined ad­vi­so­ry com­mit­tees for Non­pre­scrip­tion Drug and Anes­thet­ic, and Anal­gesic Drug Prod­ucts, vot­ed 19-0 in fa­vor of the com­pa­ny’s pro­posed OTC Nar­can 4-mg nasal spray.

“The ben­e­fits clear­ly out­weigh the risks and the ur­gency is def­i­nite­ly para­mount. I ac­tu­al­ly had a friend who lost her 19-year-old son about four days ago,” said com­mit­tee mem­ber Michael Sprintz, clin­i­cal as­sis­tant pro­fes­sor at Uni­ver­si­ty of Texas Health Sci­ence Cen­ter Hous­ton. “I think this is a won­der­ful thing we did to­day.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN